Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

Patients with metastatic non small cell lung cancer with high risk location or size are treated with prophylactic radiation therapy in conjunction with standard of care systemic therapy.

NCT Number	NCT06262321
Lead Sponsor	University of Rochester
Conditions	Stage 4 NSCLC, Radiotherapy
Enrollment	48 participants
Start Date	2024-05-15
Primary Completion	2029-02-01 (estimated)
Study Completion	2029-02-01 (estimated)
Updated on ClinicalTrials.gov	2025-09-08